Addentax Group (ATXG) grants COO Wu Rui 66,667 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Wu Rui reported acquisition or exercise transactions in this Form 4 filing.
Addentax Group Corp. granted Chief Operating Officer Wu Rui 66,667 shares of common stock. The shares were awarded at a price of $0.00 per share under the Addentax Group Corp. 2024 Equity Incentive Plan, bringing Wu Rui’s direct holdings to 66,667 shares.
The grant was approved by the Compensation Committee on March 24, 2026, and the award agreement was executed on April 8, 2026, the same date reported for the transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Wu Rui
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 66,667 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 66,667 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Shares granted: 66,667 shares
Grant price: $0.00 per share
Holdings after grant: 66,667 shares
+3 more
6 metrics
Shares granted
66,667 shares
Common stock grant to COO Wu Rui on April 8, 2026
Grant price
$0.00 per share
Stated transaction price for equity award
Holdings after grant
66,667 shares
Total common shares directly held by Wu Rui after transaction
Plan name
Addentax Group Corp. 2024 Equity Incentive Plan
Plan under which the 66,667-share grant was made
Committee approval date
March 24, 2026
Compensation Committee approval of the grant
Award execution date
April 8, 2026
Award agreement execution and transaction date
Key Terms
2024 Equity Incentive Plan, Compensation Committee, grant/award acquisition, Form 4
4 terms
2024 Equity Incentive Plan financial
"granted to the reporting person pursuant to the Addentax Group Corp. 2024 Equity Incentive Plan"
Compensation Committee financial
"The grant was approved by the Compensation Committee on March 24, 2026"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
grant/award acquisition financial
"transaction_action: grant/award acquisition with code A for the common stock"
Form 4 regulatory
"INSIDER FILING DATA (Form 4): transaction reported for Wu Rui"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What insider transaction did Addentax Group Corp. (ATXG) report for Wu Rui?
Addentax reported that Chief Operating Officer Wu Rui received 66,667 shares of common stock as a grant. The award was made under the company’s 2024 Equity Incentive Plan at a stated price of $0.00 per share, increasing direct holdings to 66,667 shares.
Was the Addentax (ATXG) Form 4 transaction a purchase or a grant?
The Form 4 shows a grant/award acquisition, not an open-market purchase. Wu Rui received 66,667 common shares at $0.00 per share as equity compensation under the 2024 Equity Incentive Plan, rather than buying shares in the market.
Under which plan was Wu Rui’s Addentax (ATXG) stock grant made?
The shares were granted under the Addentax Group Corp. 2024 Equity Incentive Plan. This plan is used to award equity compensation, and the Form 4 specifies that the 66,667-share grant to Wu Rui was made pursuant to this plan.
When was Wu Rui’s Addentax (ATXG) equity award approved and executed?
The grant was approved by the Compensation Committee on March 24, 2026, according to the footnote. The related award agreement was then executed on April 8, 2026, which is also the transaction date reported in the Form 4 data.
Does the Addentax (ATXG) Form 4 for Wu Rui involve any derivative securities?
The provided filing data indicates no derivative securities for this transaction. It shows a single non-derivative common stock grant of 66,667 shares, and the derivative position summary is empty, meaning no options or similar instruments are listed here.